Condition: Hemophilia A · Hemophilia B · Sponsor: Pfizer
A study to learn about the long-term safety and efficacy of giroctocogene fitelparvovec or fidanacogene elaparvovec in patients with hemophilia A or hemophilia B respectively, who have received treatment through prior participation in a Pfizer-sponsored clinical trial. Data collection and participant visits will be based on standard of care.
This description comes directly from the study's public registry record.
Pfizer CT.gov Call Center · 1-800-718-1021 · ClinicalTrials.gov_Inquiries@pfizer.com
Always discuss trial participation with your own doctor first.
| The Regents of the University of California||UC Davis Health | Rancho Cordova, California, United States | Recruiting |
| UC Davis Health | Sacramento, California, United States | Recruiting |
| UC Davis Ambulatory Care Clinic | Sacramento, California, United States | Recruiting |
| UC Davis Hemophilia Treatment Center | Sacramento, California, United States | Recruiting |
| UC Davis Medical Center | Sacramento, California, United States | Recruiting |
| UCSF Outpatient Hematology Clinic | San Francisco, California, United States | Not Yet Recruiting |
| USF Health Morsani Center For Advanced Healthcare | Tampa, Florida, United States | Recruiting |
| The University of South Florida Board of Trustees | Tampa, Florida, United States | Recruiting |
| Mississippi Center For Advanced Medicine | Madison, Mississippi, United States | Terminated |
| Cornell University||Joan & Sanford I. Weill Medical College | New York, New York, United States | Recruiting |
| Weill Cornell Medical College-New York Presbyterian Hospital | New York, New York, United States | Recruiting |
| The Childrens Hospital of Philadelphia Division of Hematology | Philadelphia, Pennsylvania, United States | Recruiting |
+ 11 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05568719